Details

Last Funding Type

Grant

Last Funding Money Raised

€2.16M

Industries

Biotechnology,Genetics,Therapeutics

Founded date

Jan 1, 2014

Number Of Employee

1 - 10

Operating Status

Active

Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Xenothera creates new therapeutic modes in numerous domains from immunomodulation to infectious diseases.

Xenothera's technological platform is built on a double expertise of animal genetics and mastery of immunology processes. It renovates passive immunotherapy by marketing a new generation of hyperimmune polyclonal sera.

Xenothera’s platform ensures short-time development thanks to their mastery of the entire process, from animal genetics, choice of the immunogen, selection, and purification of interesting immunoglobulins, and access to market authorization in accelerated timescale.